[Advances in the study of the integrin alpha(v) beta3 antagonists].
Ni
Guang-hui
GH
School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Jiang
Feng-chao
FC
D000085:Acetates / Q000737:chemistry; D000631:Aminopyridines / Q000737:chemistry; D020533:Angiogenesis Inhibitors / Q000737:chemistry*; D001570:Benzodiazepinones / Q000737:chemistry; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000037:antagonists & inhibitors* / Q000737:chemistry; D008024:Ligands; D015394:Molecular Structure; D009842:Oligopeptides / Q000737:chemistry; D010456:Peptides, Cyclic / Q000737:chemistry; D012910:Snake Venoms
D000085:Acetates; D000631:Aminopyridines; D020533:Angiogenesis Inhibitors; D001570:Benzodiazepinones; D039302:Integrin alphaVbeta3; D008024:Ligands; D009842:Oligopeptides; D010456:Peptides, Cyclic; C121648:SB 223245; C121647:SB 265123; D012910:Snake Venoms; C422910:Cilengitide; C047981:arginyl-glycyl-aspartic acid